Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

Clinical trial NCT05250063 · COMPLETED

Trial details

NCT number: NCT05250063
Sponsor: Lumos Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2022-02-18
Primary completion: 2025-01-22
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.